Drugs / PF-06273588
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01408355 | Jul → Aug 2011 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-06273588 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01408355 ↗ |
| Route | Intravenous | “Intravenous, 50 microgram, single dose” NCT01408355 ↗ |